Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Today's Bonus Article 3 Blue-Chip Stocks Built for a Rotating MarketWritten by Chris Markoch. Article Posted: 3/8/2026. 
Article Highlights - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation occurs when investors move money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that has meant rotating away from mega-cap technology names and into value-oriented, defensive sectors such as energy and consumer staples. The key word is "overvalued." Big tech has run hot for more than two years, largely driven by the rise of artificial intelligence (AI). Despite worries about a repeat of the dot-com bubble, many investors have largely ignored lofty valuations. Right now, as the conflict with Iran intensifies, there's one company quietly protecting every branch of the U.S. military.
Army. Navy. Air Force. Marines.
That company is Elon Musk's SpaceX. Click here and I'll show you exactly how. But investors who believed this time was different are finding that valuation doesn't matter—until it does. As the economy heats up, investors are looking for value elsewhere, including in blue-chip defensive names like the stocks highlighted below. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a large utility provider serving the Southeast and Midwest United States. Utilities stocks are typically defensive, value-oriented and income-generating, and Duke offers a relatively attractive, secure dividend that yields around 3.2%. The company has increased its payout for 20 consecutive years. The evolving U.S. energy landscape is opening a window for future growth in DUK stock. Duke follows an "all-of-the-above" approach to power generation, including nuclear, hydroelectric and natural gas. Natural gas helped drive the stock's strong bounce in 2026, but the company's steady revenue base from residential utility customers—together with projected growth from areas such as data centers—has made DUK a target for investors rotating into defensive names. DUK is up nearly 12% in 2026, putting the stock within about 5% of its consensus price target of $136.87, which would push it above its 52-week high. At roughly 20.5x earnings, DUK trades at a slight premium to its historical average. Since reporting earnings in February, analysts have been raising price targets amid expectations of strong year-over-year revenue growth in the second half of the year, which could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology to benefit from the current sector rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare, a sector that has lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by a pipeline that includes more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026 and may see a label expansion for Trodelvy, its breast cancer drug. GILD is up nearly 18% in 2026, a run that pushed the stock to a 52-week high. It is now slightly below that peak, likely due to some profit-taking after the outsized move—creating a potential buy-the-dip opportunity. Analysts' consensus price target is $156.72, implying a gain of roughly 8%. Since Gilead's February earnings report, many analysts have raised targets, with the highest calls near $170. Gilead also pays a reliable dividend, yielding about 2.28%, and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been a strong beneficiary of the rotation into consumer staples. HSY is up nearly 25% in 2026 and has broken out of the bearish trend that began in 2023. Hershey faced headwinds from elevated cocoa prices through 2025, which will continue to pressure earnings in 2026. Still, the market is forward-looking, and analysts are forecasting stronger earnings and revenue growth later in the year. HSY is trading above its consensus price target of $222.21, but analysts have been lifting targets since the company's February earnings report. The most bullish call comes from Goldman Sachs, which has a $267 target. In that report, Hershey raised its dividend by 5.9%, marking 15 consecutive years of increases. The stock yields about 2.5% and carries an annual payout per share of $5.81. After the recent run-up, HSY trades at more than 50x earnings, which likely contributed to heavy institutional selling last quarter. That premium valuation, however, could offer investors another chance to buy into this well-known consumer name.
| 
